Search - tctmd.com

Displaying 801 - 820 of 948

Sort: Relevancy | Date

Presentation ACC 2016

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis

Presenter: Craig R. Smith

April 03, 2016

Presentation ACC 2016

Relationship Between Procedure Volume and Outcome for Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: Insights from the STS-ACC TVT Registry

Presenter: John D. Carroll

April 03, 2016

Presentation ACC 2016

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis

Presenter: Vinod Thourani

April 01, 2016

Presentation ECHO 2016

Assessing Patients after Transcatheter Aortic Valve Replacement: VARC3

Presenter: Philippe Pibarot

March 21, 2016

Presentation

Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety

Presenter: Darren Mylotte

March 06, 2016

Presentation

Mechanical vs Bioprosthetic Aortic Valve Replacement in Patients Aged 40 to 70 Years

Presenter: J.J. Wu

January 14, 2016

Presentation

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Presenter: William Wilson

December 22, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

Presentation TCT 2015

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Thierry Lefevre

October 15, 2015

Presentation TCT 2015

MISTRAL C: A Prospective Randomized Trial of Embolic Protection During Transcatheter Aortic Valve Replacement

Presenter: Bernard J. Gersh, Thomas F. Luscher, Nicolas M. Van Mieghem

October 14, 2015

Presentation TCT 2015

TCT 82: Single Versus Dual Antiplatelet Therapy in Transcatheter Aortic Valve Replacement A Meta-analysis of Safety and Efficacy Outcomes

Presenter: Lisa K. Jennings, Neal S. Kleiman, Rhanderson Cardoso

October 13, 2015

Presentation TCT 2015

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

Presenter: Michael J. Reardon, Torsten P. Vahl, Henrique Ribeiro

October 13, 2015

Presentation TCT 2015

TCT 97: Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis First Report From the Transcatheter Valve Therapies Registry

Presenter: Jeffrey J. Popma, Mathew Williams

October 13, 2015

Presentation TCT 2015

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

Presenter: Michael J. Reardon, Torsten P. Vahl, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Melissa Daubert

October 13, 2015

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Presentation TCT 2015

TCT 92: Transcatheter Aortic Valve Replacement in Asian Pacific Countries

Presenter: Jeffrey J. Popma, Mathew Williams, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

Presentation TCT 2015

Development of TAVR in China: Clinical Data and Experience

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yuejin Yang

October 11, 2015

Advertisement

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis

Relationship Between Procedure Volume and Outcome for Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: Insights from the STS-ACC TVT Registry

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis

Assessing Patients after Transcatheter Aortic Valve Replacement: VARC3

Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety

Mechanical vs Bioprosthetic Aortic Valve Replacement in Patients Aged 40 to 70 Years

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

MISTRAL C: A Prospective Randomized Trial of Embolic Protection During Transcatheter Aortic Valve Replacement

TCT 82: Single Versus Dual Antiplatelet Therapy in Transcatheter Aortic Valve Replacement A Meta-analysis of Safety and Efficacy Outcomes

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

TCT 97: Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis First Report From the Transcatheter Valve Therapies Registry

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

TCT 92: Transcatheter Aortic Valve Replacement in Asian Pacific Countries

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Development of TAVR in China: Clinical Data and Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content